2487 — Cutia Therapeutics Share News
0.000.00%
Last trade - 00:00- HK$261.16m
- -HK$151.72m
- CNY336.15m
Brief: Cutia Therapeutics Announces Inclusion Of Co In FTSE Global Equity Index Series
Brief: Cutia Therapeutics Says Q4 Revenue Of Group's Commercialized Products RMB72.8 Million
Brief: Cutia Therapeutics Says New Drug Application For CU-40102 (Topical Finasteride Spray) Accepted
Brief: Cutia Therapeutics Says Registrational Phase III Clinical Trial Of CU-40102 Reached Primary Endpoint
Brief: Cutia Therapeutics Says Q3 Revenue Of Group's Commercialized Products RMB 30.5 Mln
Brief: Cutia Therapeutics Says New Drug Application For Cu-10201 Accepted By NMPA
HK-listed Cutia Therapeutics at 11-week high on inclusion in Stock Connect
Brief: Cutia Therapeutics Subscribes For Wealth Management Products
Brief: Cutia Therapeutics Posts Q2 Revenue Of Group's Commercialized Products Of Rmb21.0 Mln